Some drugs are missing in Oncology, SKKKUK says they don't have authorization

Oncology is one of the clinics facing the problem of lack of drugs. Institutes that provide medicine supplies, which tell Dukagjin that they are having trouble buying certain drugs that are needed to treat cancer patients, are recently announced.

By morning, he's standing in front of the doors of Oncology.

Vedat Dina from the municipality of Rahovec has come to the clinic to bring his sister-in-law to receive the fifth therapy against cancer.

Although he says that the shepherd's care is good, he shows that as a result of his lack of drugs, his family has had to buy some species now and several sessions.

“We bought two drugs, I found him missing. What they're giving here is what they don't have to buy. These two species had to get out of my hospital after they were missing, ”, proclaimed Vedat Dina of Rahoveci.

Oncology Clinic Director Ilir Kurteshi has said they are well supplied, until for some lack he has asked questions to be addressed to the Kosovo University Hospital Hospital Service Central Barattore.

And from the latter, drugs that are missing in the clinic have been listed until he said that their insurance is being explained for the main reason he's leading to no supply of certain types of drugs.

“With Enteral Food Products, we're already supplied, and for Sunitib products, Erlotinib and Bicatulade we're waiting for the delivery of economic operator. While the pantoprazol product is in the process of evaluating the procurement office because it is a product that has been introduced to the new essential list. Other products are products that do not have Marketing Authorisation in the Republic of Kosovo, and in co-operation with the Ministry of Health we are in co-ordination for alternative procurement solutions for these products”, the SSKUK says.

According to SKKUK, Oncology is supplied with about 90 %s of products needed for labour management.

While for the missing drugs, the Ministry of Health has provided no answers until for the list of essential drugs, this ministry had allocated about 60m euros for 2023. /Dukagini/